SYK

Stryker Corporation

Healthcare
294.66 up +1.43 +0.49% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 113.02B
EV 124.58B
Shares Out 383.57M
Revenue (ttm) 25.84B
Net Income 3.73B
Beta —
P/E —
Forward P/E —
EPS (ttm) $9.65
P/S 4.37
P/B 4.71
P/FCF 24.03
P/C 20.45
EV/Sales 4.82
EV/EBITDA 17.41
ROA 7.85%
ROE 16.29%
ROIC 10.3%
Gross Margin 64.98%
Oper. Margin 21.42%
Profit Margin 14.43%
Debt/Eq 0.62
LT Debt/Cap 37.17%
Quick Ratio 1.07
Current Ratio 2.16
Book/sh 62.55
Cash/sh 8.84
Div Yield 1.17%
Div TTM $3.44
Payout Ratio 35.65%
SMA20 5.79%
SMA50 -1.76%
SMA200 -9.79%
Volume 3,377,110
Avg Volume 2.62M
Rel Volume 1.29
Perf Week 4.27%
Perf Month 7.10%
Perf Quarter -7.88%
Perf Half Y -14.17%
Perf YTD -16.16%
Perf Year -21.30%
Perf 3Y 9.78%
Perf 5Y 8.79%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.8800
TTM Yield 1.17%
TTM Amount $3.44
Payout Ratio 35.65%
3-Yr Growth (CAGR) —
5-Yr Growth (CAGR) —

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-30 $0.8800
Q1 2026 ~2026-03-31 $0.8800
Q3 2025 ~2025-09-30 $0.8400
Q2 2025 ~2025-06-30 $0.8400
Q1 2025 ~2025-03-31 $0.8400
Q3 2024 ~2024-09-30 $0.8000
Q2 2024 ~2024-06-30 $0.8000
Q1 2024 ~2024-03-31 $0.8000
Q3 2023 ~2023-09-30 $0.7500
Q2 2023 ~2023-06-30 $0.7500
Q1 2023 ~2023-03-31 $0.7500
Q3 2022 ~2022-09-30 $0.6950

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Stryker Corporation is a global leader in medical technologies that together with its customers is driven to make healthcare better. The Company offers innovative products and…

Name
Stryker Corporation
Sector
Healthcare
Industry
Medical Devices
CEO
Kevin A. Lobo · Chair and Chief Executive Officer
Employees
43,000 as of 2025-12-31
IPO Date
2017-02-07
Phone
(269) 385-2600
Address
1941 Stryker Way, Portage, MI 49002
Website
www.stryker.com

Key Executives

Name Title FY Pay
Viju S. Menon Executive Vice President, Operations and Supply Chain —
J. Andrew Pierce Group President, MedSurg and Neurotechnology —
Spencer S. Stiles Group President, Orthopaedics —
Preston W. Wells Chief Financial Officer —
Kevin A. Lobo Chair and Chief Executive Officer —

Latest News